Novartis is a pharmaceutical company created in Switzerland in 1996 through a merger of Ciba-Geigy and Sandoz. Novartis and its predecessor companies trace roots back more than 250 years, with a rich history of developing innovative products. Novartis uses science-based innovation to address some of society’s most challenging healthcare issues.
Novartis discovers and develops breakthrough treatments and finds new ways to deliver them to as many patients as possible. In 2017 Novartis invested about €4.5m in R&D and infrastructure in Bulgaria. This investment includes 67 clinical trials, 27 of them in Oncology, which have provided access to innovative therapies and clinical monitoring for 1500 Bulgarian patients.
Novartis has almost 200 medicinal products in its portfolio in Bulgaria. Novartis is a key partner of healthcare professionals, patients, institutions and society.